Literature DB >> 30404912

Inhibition of tumor growth by agonists of growth hormone-releasing hormone.

Hippokratis Kiaris1,2, Ioulia Chatzistamou3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30404912      PMCID： PMC6255184          DOI： 10.1073/pnas.1817342115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  22 in total

1.  Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice.

Authors:  Xianyang Zhang; Tengjiao Cui; Jinlin He; Haibo Wang; Renzhi Cai; Petra Popovics; Irving Vidaurre; Wei Sha; Janine Schmid; Barbara Ludwig; Norman L Block; Stefan R Bornstein; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-16       Impact factor: 11.205

Review 2.  Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis.

Authors:  A V Schally
Journal:  Peptides       Date:  1999       Impact factor: 3.750

3.  Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

Authors:  Z Rekasi; T Czompoly; A V Schally; G Halmos
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

4.  Expression of the rat growth hormone-releasing hormone gene in placenta is directed by an alternative promoter.

Authors:  S González-Crespo; A Boronat
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

5.  Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation.

Authors:  X F Yang; W G Beamer; H Huynh; M Pollak
Journal:  Cancer Res       Date:  1996-04-01       Impact factor: 12.701

Review 6.  Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.

Authors:  Andrew V Schally; Jozsef L Varga; Jörg B Engel
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-01

7.  New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.

Authors:  Rosemeire M Kanashiro-Takeuchi; Luca Szalontay; Andrew V Schally; Lauro M Takeuchi; Petra Popovics; Miklos Jaszberenyi; Irving Vidaurre; Marta Zarandi; Ren-Zhi Cai; Norman L Block; Joshua M Hare; Ferenc G Rick
Journal:  Oncotarget       Date:  2015

Review 8.  Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis.

Authors:  Xiangyang Xia; Quanwei Tao; Qunchao Ma; Huiqiang Chen; Jian'an Wang; Hong Yu
Journal:  Stem Cells Int       Date:  2016-09-27       Impact factor: 5.443

Review 9.  Growth Hormone-Releasing Hormone in Diabetes.

Authors:  Leonid E Fridlyand; Natalia A Tamarina; Andrew V Schally; Louis H Philipson
Journal:  Front Endocrinol (Lausanne)       Date:  2016-10-10       Impact factor: 5.555

10.  Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways.

Authors:  Tengjiao Cui; Joaquin J Jimenez; Norman L Block; Evangelos V Badiavas; Luis Rodriguez-Menocal; Ailin Vila Granda; Renzhi Cai; Wei Sha; Marta Zarandi; Roberto Perez; Andrew V Schally
Journal:  Oncotarget       Date:  2016-08-16
View more
  2 in total

1.  GHRH antagonists support lung endothelial barrier function.

Authors:  Mohammad A Uddin; Mohammad S Akhter; Sitanshu S Singh; Khadeja-Tul Kubra; Andrew V Schally; Seetharama Jois; Nektarios Barabutis
Journal:  Tissue Barriers       Date:  2019-10-03

2.  Growth Hormone Releasing Hormone in Endothelial Barrier Function.

Authors:  Nektarios Barabutis
Journal:  Trends Endocrinol Metab       Date:  2021-03-23       Impact factor: 10.586
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.